Fever in a lung transplant recipient

REFERENCES

1. ↵
   1. Skinner J,
   2. Yankey B,
   3. Shelton BK

   . Hemophagocytic lymphohistiocytosis. AACN Adv Crit Care 2019; 30(2):151–164. doi:10.4037/aacnacc2019463

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Boisseau M,
   2. Lambotte O,
   3. Galicier L, et al

   . Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome. Infect Dis (Lond) 2015; 47(6):423–427. doi:10.3109/00365548.2015.1007475

   OpenUrlCrossRef
3. ↵
   1. Rivière S,
   2. Galicier L,
   3. Coppo P, et al

   . Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 2014; 127(11):1118–1125. doi:10.1016/j.amjmed.2014.04.034

   OpenUrlCrossRefPubMed
4. ↵
   1. Marik PE,
   2. Taeb AM

   . SIRS, qSOFA and new sepsis definition. J Thorac Dis 2017; 9(4):943–945. doi:10.21037/jtd.2017.03.125

   OpenUrlCrossRefPubMed
5. ↵
   1. Dioverti MV,
   2. Razonable RR

   . Cytomegalovirus. Microbiol Spectr 2016; 4(4). doi:10.1128/microbiolspec.DMIH2-0022-2015

   OpenUrlCrossRef
6. ↵
   1. Ljungman P,
   2. Griffiths P,
   3. Paya C

   . Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34(8):1094–1097. doi:10.1086/339329

   OpenUrlCrossRefPubMed
7. ↵
   1. Verbeeck J,
   2. Van Kerschaver E,
   3. Wollants E,
   4. Beuselinck K,
   5. Stappaerts L,
   6. Van Ranst M

   . Detection of perinatal cytomegalovirus infection and sensorineural hearing loss in Belgian infants by measurement of automated auditory brainstem response. J Clin Microbiol 2008; 46(11):3564–3568. doi:10.1128/JCM.00757-08

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Ruuskanen O,
   2. Lahti E,
   3. Jennings LC,
   4. Murdoch DR

   . Viral pneumonia. Lancet 2011; 377(9773):1264–1275. doi:10.1016/S0140-6736(10)61459-6

   OpenUrlCrossRefPubMed
9. ↵
   1. Nakanishi M,
   2. Yoshida Y,
   3. Takeda N, et al

   . Community-acquired pneumonia distinguished from influenza infection based on clinical signs and symptoms during a novel (swine) influenza A/H1N1 pandemic. Prim Care Respir J 2011; 20(4):421–426. doi:10.4104/pcrj.2011.00067

   OpenUrlCrossRefPubMed
10. ↵
    1. Allyn PR,
    2. Duffy EL,
    3. Humphries RM, et al

    . Graft loss and CLAD-onset is hastened by viral pneumonia after lung transplantation. Transplantation 2016; 100(11):2424–2431. doi:10.1097/TP.0000000000001346

    OpenUrlCrossRef
11. ↵
    1. Dierickx D,
    2. Habermann TM

    . Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 2018; 378(6):549–562. doi:10.1056/NEJMra1702693

    OpenUrlCrossRefPubMed
12. ↵
    1. Kremer BE,
    2. Reshef R,
    3. Misleh JG, et al

    . Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases. J Heart Lung Transplant 2012; 31(3):296–304. doi:10.1016/j.healun.2011.10.013

    OpenUrlCrossRefPubMed
13. ↵
    1. Kumarasinghe G,
    2. Lavee O,
    3. Parker A, et al

    . Post-transplant lymphoproliferative disease in heart and lung transplantation: defining risk and prognostic factors. J Heart Lung Transplant 2015; 34(11):1406–1414. doi:10.1016/j.healun.2015.05.021

    OpenUrlCrossRef
14. 1. Cockfield SM

    . Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3(2):70–78. doi:10.1034/j.1399-3062.2001.003002070.x

    OpenUrlCrossRefPubMed
15. ↵
    1. Minárovits J,
    2. Niller H

    . Epstein Barr Virus: Methods and Protocols. Totowa, NJ: Humana Press; 2016.
16. ↵
    1. Luskin MR,
    2. Heil DS,
    3. Tan KS, et al

    . The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder. Am J Transplant 2015; 15(10):2665–2673. doi:10.1111/ajt.13324

    OpenUrlCrossRefPubMed
17. ↵
    1. Cao S,
    2. Cox KL,
    3. Berquist W, et al

    . Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant 1999; 3(1):22–26. doi:10.1034/j.1399-3046.1999.00002.x

    OpenUrlCrossRefPubMed
18. ↵
    1. McKeage K,
    2. McCormack PL

    . Basiliximab: a review of its use as induction therapy in renal transplantation. BioDrugs 2010; 24(1):55–76. doi:10.2165/11203990-000000000-00000

    OpenUrlCrossRefPubMed
19. ↵
    1. Humar A,
    2. Mazzulli T,
    3. Moussa G, et al

    . Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant 2005; 5(5):1065–1070. doi:10.1111/j.1600-6143.2005.00797.x

    OpenUrlCrossRefPubMed
20. ↵
    1. Maylin S,
    2. Feghoul L,
    3. Salmona M, et al

    . Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation. J Med Virol 2017; 89(11):2003–2010. doi:10.1002/jmv.24889

    OpenUrlCrossRef
21. ↵
    1. Epstein MA,
    2. Achong BG,
    3. Barr YM

    . Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 1(7335):702–703. doi:10.1016/s0140-6736(64)91524-7

    OpenUrlCrossRefPubMed
22. ↵
    1. Crawford D,
    2. Johannessen I,
    3. Rickinson AB

    . Cancer Virus: The Story of Epstein-Barr Virus. New York, NY: Oxford University Press; 2014.
23. 1. Pope JH,
    2. Horne MK,
    3. Scott W

    . Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 1968; 3(6):857–866. doi:10.1002/ijc.2910030619

    OpenUrlCrossRefPubMed
24. ↵
    1. Penn I,
    2. Hammond W,
    3. Brettschneider L,
    4. Starzl TE

    . Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1(1):106–112. pmid:4944206

    OpenUrlPubMed
25. ↵
    1. Bow EJ,
    2. Evans G,
    3. Fuller J, et al

    . Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 2010; 21(4):e122–e150. doi:10.1155/2010/357076

    OpenUrlCrossRefPubMed
26. 1. Marchetti O,
    2. Cordonnier C,
    3. Calandra T

    . Empirical antifungal therapy in neutropaenic cancer patients with persistent fever. Eur J Cancer Suppl 2007; 5(2):32–42. doi:10.1016/j.ejcsup.2007.06.005

    OpenUrlCrossRef
27. ↵
    1. Taplitz RA,
    2. Kennedy EB,
    3. Bow EJ, et al

    . Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 2018; 36(14):1443–1453. doi:10.1200/JCO.2017.77.6211

    OpenUrlCrossRefPubMed
28. ↵
    1. Green M,
    2. Michaels MG

    . Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 2013; 13(suppl 3):41–54. doi:10.1111/ajt.12004

    OpenUrlCrossRefPubMed
29. ↵
    1. Span AH,
    2. van Dam-Mieras MC,
    3. Mullers W,
    4. Endert J,
    5. Muller AD,
    6. Bruggeman CA

    . The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 1991; 21(3):331–338. doi:10.1111/j.1365-2362.1991.tb01378.x

    OpenUrlCrossRefPubMed
30. ↵
    1. Tsai DE,
    2. Hardy CL,
    3. Tomaszewski JE, et al

    . Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001; 71(8):1076–1088. doi:10.1097/00007890-200104270-00012

    OpenUrlCrossRefPubMed
31. ↵
    1. Dharnidharka VR,
    2. Mohanakumar T

    . New approaches to treating B-cell cancers induced by Epstein-Barr virus. N Engl J Med 2015; 372(6):569–571. doi:10.1056/NEJMcibr1415117

    OpenUrlCrossRef
32. ↵
    1. Oertel SH,
    2. Verschuuren E,
    3. Reinke P, et al

    . Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 2005; 5(12):2901–2906. doi:10.1111/j.1600-6143.2005.01098.x

    OpenUrlCrossRefPubMed
33. ↵
    1. Mendogni P,
    2. Henchi S,
    3. Morlacchi LC, et al

    . Epstein-Barr virus-related post-transplant lymphoproliferative disorders in cystic fibrosis lung transplant recipients: a case series. Transplant Proc 2019; 51(1):194–197. doi:10.1016/j.transproceed.2018.05.032

    OpenUrlCrossRef
34. ↵
    1. Kinch A,
    2. Baecklund E,
    3. Backlin C, et al

    . A population-based study of 135 lymphomas after solid organ transplantation: the role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival. Acta Oncol 2014; 53(5):669–679. doi:10.3109/0284186X.2013.844853

    OpenUrlCrossRefPubMed
35. ↵
    1. Ison MG,
    2. Grossi P; AST Infectious Diseases Community of Practice

    . Donor-derived infections in solid organ transplantation. Am J Transplant 2013; 13(suppl 4):22–30. doi:10.1111/ajt.12095

    OpenUrlCrossRefPubMed